A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University Hospitals Seidman Cancer Center in Cleveland has identified the first validated predictive ...

Detection of a bowel cancer marker (CDH1) in wastewater may offer a new community level early warning system for the disease, suggests a proof of concept study published online in the Journal of ...

ORNL is a leader both in developing advanced radiotherapies and in providing the radioisotopes needed for those therapies.

Tagawa, MD, identified 3 primary clinical scenarios where PSMA PET scans have become the established standard for prostate cancer care. The first application is initial s ...

Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, research has demonstrated that combining ADT with additional agents ...

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...

Timing is critical in diagnosing diseases such as cancer. Researchers within The Grainger College of Engineering at the University of Illinois Urbana-Champaign used a historically underappreciated ...

Dr. Alexandre Zlotta delivered the State-of-the-art lecture Who really needs surgery after neo-adjuvant chemotherapy? Dr.

Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...

A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...